Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets
The PIK3 CA gene encodes the p110 α protein subunit and is one of the most efficient cancer genes in solid and hematological tumors including hepatocellular carcinoma (HCC). There are currently ongoing therapies against tumors based on PIK3 CA inhibition. Because microRNAs (miRNAs) play an important role in post-transcriptional reg ulation and are also involved in the inhibition of PIK3 CA expression to suppress cancer cell proliferation, overexpression of tumor-suppressive miRNA is a promising therapeutic approach for HCC therapy.
Source: Ultrasound in Medicine and Biology - Category: Radiology Authors: Wei Dong, Pengying Wu, Di Zhou, Jixiu Huang, Mengfan Qin, Xinxing Yang, Mingxi Wan, Yujin Zong Tags: Original Contribution Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Gene Therapy | Genetics | Hematology | Hepatocellular Carcinoma | Liver Cancer | Men | Nanotechnology | Radiology | Ultrasound